Triple
T2371048
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Rituxan |
E46089
|
entity |
| Predicate | hasBiosimilar |
P37220
|
FINISHED |
| Object |
Truxima
Truxima is a monoclonal antibody biosimilar to rituximab used to treat certain cancers and autoimmune diseases by targeting the CD20 protein on B cells.
|
E46089
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69a88a145268819083e2736cb835c696 |
elicitation | completed |
| NER | batch_69abc76f5aec8190867d621e6849258c |
ner | completed |
| NED1 | batch_69aeb3c81430819081654a90df17c5c0 |
ned_source_triple | completed |
| NED2 | batch_69aeb59d0e5c819080bf5b34946b68ac |
ned_description | completed |
| NEDg | batch_69aeb4a5011c8190bda6c487dab73131 |
nedg | completed |
Created at: March 4, 2026, 7:56 p.m.